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ABSTRACT

An extract from Eisenia bicyclis containing -principally
a polyphenolic polymer was examined for pharmacological activity.

The investi gat ion centered around the established

activity of a model polyphenolic compound, phloroglucinol.
Studies on inflammation and alteration of hepatic microsomal
enzyme activity were also performed.
Heat denat uration of a 0.15 % bovine serum al bumin solution was inhibited 96% by the addition of the material at a
final concentration of 0.32 mg/ml.

Since stabilization of

such solutions is often indicative 9f anti-inflammatory activity, direct me asurements of this. activity were made .

The

inhibition of formation of carageenin-induced rat paw edema
was utilized as a test system.

As determined by paw volume

changes, administration of a dose of 75 mg/kg (ip) one hour
prior to carrageenin injection inhibited edema production by

88%.

The potent anti-inflammatory agent phenylbutazone, at

a dose of 90 mg/kg (i p), provided 100% protection.

The pro-

tection given by the Eisenian extract apparently was not due
to pituitary-adrenal stimulation, since the protection is 4- ·
fold better than that given by a dose of 50 mg/kg ( ip ) of
cortisone.

The effect cannot be attributed to changes in

body temperature, which r emai ns unc hanged .

The effect can

be partially but not completely attributed to the irr·itant
i

properties of the material since buffering a dose of 100
mg/kg (ip) provided 42% protection.

The effect is partially

due to stabilization of the lysosomal membrane since in
vitro 309 ug of the extract per milliliter of incubation
media inhibited by 64 % the release of the marker enzyme
8-glucuronidase from lysosomes.

The compound administered

at a dose of 75 mg/kg (i p) daily for 17 days offered no
protection against rat paw edema induced by Freund's complete adjuvant.
Capillary fragility was determined by mouse lung hemoglobin content following sudden decompression.

No decrease

in fra gility was observed 1.5 hours after pretreatment with
the extract at a dose o f 300 mg/kg (ip).
The material administered to mice (3 00 mg/k g , ip) 30
minutes prior to administration of lethal doses of curare
exhibited p1"otection when the curare was also given by the
intraperitoneal route .

No protection was exhibited when the

curare was administered subcutaneously,

This s uggested a

chemical rather than a pharmacological antagonism.

Th:l.s

hypothesis was supported when no hlltagon1sm was found to the
action of curare on the cat gastrocnemius muscle in vivo by
jugular infusion of 180 mg of the extract, and when a dose
of 300 mg/kg (ip) one hour

pr~or

to sacrifice was found to

have no effect on the activity of rat brain cholinesterase.
The extract offe red no antagonism to the action of either
stryc hnine or tetrodotoxin.
No chan ge in rat liver mi crosomal enzyme activity, as
ii

determined by the extent of metabolism of 0-ethyl
0-(4-nitrophenyl) phenylphosphonothioate (EPN1 was found
after the administration of 300 mg/kg (ip) of the material
daily for 3 days.

Also, a single injection of 300 mg/kg (ip)

1 hour prior to sacrifice for measurement of activity was

without effect.
Estrogenic activity was assayed by changes in uterine
weight in the immature female rat.

The administration of

300 mg/kg of the extract intraperitoneally daily for 3 days
did not alter uterine weight .
Rat liver homogenates were assayed for tryptophan
pyrrolase activity by measuring the formation of the endproduct kynurenine.

The administration of 300 mg/kg (ip) of

the extract 1.5 hours prior to sacrifice caused 33% inhibition of the enzyme activity .

The presence of the extract at

a concentration of 486 µg/ml resulted in an in vitro inhibition of 82%.
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I

INTRODUCTION

Many naturally derived compounds are used extensively
in medicine .

Some outstandi ng examples are digitalis, re-

serpine, atropine, and colchicine.

Despite the awareness of

the ori gi ns of such drugs from terrestrial plants, until
recently there has been relatively little effort made to
examine marine species for pharmacolo gical agents.

Exten-

sive research is neede d in this are a , considering that of
the 500,000 species which inhabit the water, less than one
percent have been examined for biologi cal activity.
The drugs whi ch have been isolated from marine plants
exhibit a wide variety of pharmacological activity.

The

follo wing are some representative examples (Der Marderosian,

1969).

The fungus Ce phalosporium acremonium is the source

of cephalothin , an antibiotic which is active against various
penicill in-resistant microbes.

The algae Lyngbya majuscula

has been implicated in outbreaks of dermatitis among swimmers,
and toxicity in fi sh and mice.

However, extracts of this

algae have also shown antimicrobial, antiviral , fungicidal,
and other types of growth-inhibitory properties in preliminary pharmacological studies.

The algae Digenea simplex

has yielded the anthelmintic kainic acid.

Chondrus crispus

is the source of the linear polysaccharide carrageenin,

which exhibits antipeptic, anticoagulant, and antithrombic
properties.

More thorough screening programs would un-

doubtedly uncover more agents from just these four species.
In this study, an extract from the algae Eisenia
bicyclis (Kjel lman ) Setchell, native to the shores of Korea,
containing principally a polyphenolic polymer, has been
examined for pharmacological activity.

The investigation

centered· around the established activity of a model polyphenolic compound, phloroglucinol, or 1,3,5-trihydroxybenzene.
Studies on inflammation and alteration of hepatic microsomal
enzyme activity were also performed.
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II

REVIEW OF THE LI TERATURE

The pharmacological activity of phloroglucinol (1,3,5trihydroxybenzene) has been investi ga ted by several groups.
Okanishi and Shimaoka (1952) determined by gross observation
that phloroglucinol pretreatment could decrease mouse lung
capillary fra gil ity, utilizing a decompression hemorrhaging
technique devel oped by Majovski et al. (1944).

To induce

lung hemorrhage, mice were placed in a. chamber which was
decompressed to 40 mm Hg.

The animals were removed from the

chamber after two minutes and the lungs were excised and
judged for extent of hemorrhage according to an arbitrary
ratin g system.

A capillary stabilizing effect uncovered by

this fragility screen might find application in hypobaric
environments or in the treatment of hypertension.
Frieden et al. (1961) reported that phloroglucinol
non-comp etitively blocks the convers ion of L-tryptophan to
kynurenine by the liver enzyme tryptophan pyrrolase.

Eighty-

one percent inhibition was achieved at a concentration of
3.0 mM.

Such an inhibition in vlvo could result in nico-

tinic acid deficiency.
Mogey and Young (1949) investigated the in vitro effect
of phloroglucinol on the curarized rat diaphragm.

In this

experiment, the AD66/33 of phenol, i.e., that amount of
phenol which reduces by half the activity of an amount of

9
d-tubocurarine which by itself would have effected 66.7 percent paralysis, was established as a basis for the comparison of the antagonism offered by other phenols.
for phenol was found to be 1.52 mg.

The AD66/33

The relative activity,

on a weight for weight basis, for phloroglucinol was found to
be one-tenth that of phenol.

Thus the authors concluded

that phloroglucinol acted as a very weak curare antagonist.
No inhibition of rat brain acetylcholinesterase or pseudo
(horse serum) cholinesterase was exhibited, nor was the pH
of the medium affected enough to alter the action of the
. curare.

Thus the mechanism of the antagonism was unexplained.

It has been demonstrated that a variety of phenolic substances such as genistein and coume strol possess estrogenic
activity (Biggers and Curnow, 1954; Bickoff et al., 1958).
The administration of such agents could result in infertility due to suppressed hypophyseal gbnadotropin resulting in
a disturbed estrous cycle.
Conney (1967) discussed extensively the pharmacologi cal
implications of the alteration of the activity of the drugmetabolizing liver microsomal enzyme system.

Specifically,

the administration of certain drugs, such as phenobarbital
and 3-methylcholanthrene, results in enhanced metabolism of
other agents due to induction of the enzyme system.

Because

of this important source of drug interaction, it appears
important to test all drugs and chemical agents for the
ability to induce or inhibit drug metabo lizin g activity .
According to Neal and DuBois ( 1965 ), metabolism of the

10
pesticide 0-ethyl 0-(4-nitrophenyl) phenylphosphonothioate
(EPN) by rat liver microsomal enzymes provides an indication
of the activity of that system, thus providing a method to
investigate the effect of drugs on this metabolic pathway.
Measurement of the anti-inflammatory activity of drugs
is a complex problem and many methods and models have been
proposed and utilized.

Grant et al. (1970) demonstrated

that anti-inflammatory drugs such as aspirin and indomethacin are often capable of inhibiting the heat denaturation of bovine serum albumin solutions.

Winter et al.

(1 962 ) concluded that the polysaccharide carrageenin was
highly suited as a phlogistin in the rat paw edema model
of inflammation.

Pearson (1956) showed that Freund's com-

plete adjuvant, a suspension of heat-killed Mvcobacterium
butyricum in paraffin, when injected into the paw of the
rat, could elicit a polyarthritis syndrome which could
serve to further evaluate anti-inflammatory agents .

Van

Arman et al. (1965) described a highly sensitive mercury
displacement plethysmograph which could be employed to
quantitate rat paw volumes in conjunction with paw edema
models of inflammation.

The device is essentially a

mercury-filled syringe connected to a blood pressure transducer which is in turn wired to a polygraph amplifier.

The

introduction of objects into the mercury results in a l i near
response on the amplifier recorder.
Many mechanisms have been proposed for the action of
anti-inflammatory agents.

Labilization of the lysoso mal

11

membrane and subsequent tissue dissolution due to the release
of degradative lysosomal enzymes has been implicated as a
mechanism underlying several types of inflammation, ranging
from heat and chemical burns to arthritis (Houck and
Forscher, 1968).

Ignarro (1971), utilizing the release of

the marker enzymes $-glucuronidase and acid phosphatase from
the lysosome, has demonstrated that anti-inflammatory drugs
are often capable of stabilizing the membrane of that
organelle .

Such stabilization may therefore partially ex-

plain the mechanism of action of many anti-inflammatory
agents.
Garattini et al. (1965) indicate that many chemical
agents, such as hypertonic saline, acetic acid , and formaldehyde , when injected by a general route, possess antiinflammatory activity by virtue of

~heir

irritant properties,

which allow for a minimization of local edema formation.
The screening of new anti-inflammatory agents must therefore
account. for possible irritant effects.

12 .

III

A.

EXPERIMENTAL

Animals
Sprague-Dawley derived random bred albino rats were

obtained from Charles River Breeding Laboratories, Wilmington, Massachusetts .

Male rats employed weighed 200-250 g

while female rats weighing 55-65 g were used.

Male mice,

35-42 g , were obtained from the same breeder.

The animals

were housed in quarters maintained at 21-23°c with room
lights on alternating 12 hour li ght-dark cycles.

Com-

mercial laboratory cho w and wate r we re allowed ad libi tum .
Animals were used no earlier t han 3 days following receipt
from the supplier.
B.

Ma terials
Analytical grade chemi c als or equivalent were used

throughout the study.

Cofactors (NADP and glucose-6-

phosphate) and substrates (L-trypto phan ,

~-nitrophenyl

phosphate, phenolphthalein glucuronide, and acetylcholine
chloride) were obtained from Calbiochem or Sigma Chemicals.
Phenylbuta zone and EPN were gifts of Geigy Pharmaceuticals
and DuPont respectively.
respective manufacturers.

Drugs were obtained from their
Water employed as a solvent was

double-distilled.
The molecular weight of the Eisenian extract has been

13
determined to be about 10,000.

The extract will be referred

to as 40SA , preceded by letters which indicate the extraction
batch.
Recent evidence sugges ts that an integral part of the
polyphenolic polymer is polysaccharide (Zelenski, 1973).
C.

Analytical Procedures
All incubations except for determination of cholin-

esterase activity were carried out in a Dubnoff metabolic
shaker under an atmosphere of air.

All absorbance deter-

minations were made utilizing a Beckman DB-G spectrophotometer .

Unless otherwise indicated, all 40SA fractions

were dissolved in water or saline.
1.

Turbidime tric Determination of Heat Denaturation of

Bovine Serum Albumin
The extent of heat-induced denatura ti on of bovine
serum albumin (BSA) was quantitated by a method suggested
by Grant et al. (1970).

Equal amounts of 0.3 % BSA and
0

buffer or drug solution were heated at 70 C for 4 minutes,
cooled in ice water for 3 minutes, maintained at room
temperature for 15 minutes, and the resultant degree of
turbidity was determined by the absorbance at 660 nm.
The buffer empl oyed was 0.05 M Tris acetate, pH 6.0, and
was employed as the solvent for c40SA.

Phloroglucinol

was dissolved in buffer containing 2.5% dimethylformamide.
2.

Plethysmographic Rat Paw Volume Determination
)

Rat paw volume was determined by a plethysmographic
t e chnique described by Van Arman et al. (1965).
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A 30 cc capacity syringe was filled with mercury and
connected by means of cannula tubing to a Statham blood
pressure transducer which in turn was wired to a Grass
polygraph amplifier.

The introduction of objects into the

mercury resulted in a linear recorder output response from
the amplifier.

The apparatus was calibrated by the intro-

duction of objects of known volume.

Rat paws were prepared

for volume measurement by marking just above the topmost
callus pad.

Paws were

im~ersed

to this mark in the mercury

during measurement .

3.

Carragee nin-Induced Rat Paw Edema
Carrageenin was utilized as a phlogistin to induce

rat paw edema as suggeste d by

Winte~

et al . (1962).

Male rats were administered (ip) either saline, 90
mg/kg phenylbutazone, 50 mg/kg cortisone, or 75 mg/kg
c40SA.

One hour later, 0.1 ml of

~.0%

carrageenin in

saline was injected into the sub-plantar tissue of the
hind paw, usin g a 26 gauge needle.

The paw volume was

determined immediately plethysmographically, and again
three hours later, and edema formation was calculated in
mrn3.

4.

Determination of Thermogenic Activity
Thermo geni c activity was determined by monitoring the

rectal temperature of rats using a Yellow Springs Instrument Co. thermistor thermometer , model 8420.

Saline or

75 mg/kg or 150 mg/kg e40SA was administered (ip) to male
rats and rectal temperature was determined (2.5 cm probe
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insertion) immediately and every hour thereafter for four
hours.

Animals were housed three per cage; ambient temper-

ature was 24°c.

5.

Harvesting of Lysosomes and Determination of the Activities

of S-Glucuronidase and Acid Phosphatase
Lysosomal fractions were prepared according to the
method suggested by Ignarro (1971).

The determination of

the activities of the lysosomal enzymes S-glucuronidase
and ad.d phosphatase was also performed by the method reported

by

that author .

The liver from a decapitated and exsanguinated male
rat was excised and a 10 % homogenate prepared in cold 0 .2 5M
su crose-0.02 M Tris acetate buffer,pH 7.4.

The homo-

genate (40 ml) was then centrifuge d at 600 g for 5 min at
4°c in a Sorvall RC2-B centrifuge (·# 34 rotor).

The re-

sulting supernatant was decanted and diluted with an equal
volume of the same buffer, and cent rifuged at 3500 g for
15 min at 4°c.

The intact pellet was rinsed ge ntly twice

in 0.45 M sucrose-0.04% glycogen-0 .02 M Tris acetate buffer,
pH 7.4, and resuspended in 4.0 ml of the same buffer.

The

suspensions were maintained at 4°c.
Labilization or stabilization of lysosomes was ascertained by determining the release of lysosomal marker
enzymes.

The lysosomal suspension was warmed to 25°c for

5 min and 0.2 ml aliquots were added to 20 ml glass beakers
containing 2.0 ml of 0.18 M sucrose-0.04 M Tris acetate
buffer, pH 7.4, with either 0.1 ml drug solution or water,
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and the beakers were incubated at 37°c for O or 15 min in
a Dubnoff metabolic shaker.
by

The incubation was terminated

high speed centrifugation (27,000 g for 15 min at 4°c)

after transfer of the samples to polyethylene tubes.

When

appropriate the direct effect of the drugs on the marker
enzymes was determined.

In this case the drugs were added

to the system after the incubation period.

To determine

the total enzyme activity of the system, 2.0 ml of 0.2%
(v/v) Triton X-100 in 0.04 M Tris acetate buffer, pH 7.4,
replaced the 2.0 ml of buffer in the incubation.
Acid phosphatase and 8-glucuronidase were employed as
lysosomal marker enzymes.

The formation of 2_-ni trophenol

from E_-ni trophenyl phosphate was measured to determine ad.d
phosphatase activity .

The formation of phenolphthalein

from phenolphthalein glucuronide was estimated to assay
S-glucuronidase activity.

One milliliter of high speed

supernatant and 1 .0 ml of distilled water were added to
1.0 ml of 0.3 M citrate buffer, pH 4.8.

Incubation (at 37°c

for 20 min) was initiated by the addition of 0.04 ml of
freshly prepared substrate (either E_-nitrophenyl phosphate,
79 mg/ml in distilled water, or phenolphthalein glucuronide,

63 mg/ml in distilled water).
place of substrate.

Blanks received water in

Acid phosphatase determinations were

termina ted by the addition of 0.2 ml of 4 N NaOH, and
absorbances we r e then determi ned at 405 nm.
assays were terminated by the a ddit i on of

o.4

S-glucuronida s e
ml of 2.2 M

17
glycine-NaOH buffer, pH 12, and absorbances were then
measured at 540 nm.

The absorbances obtained were compared

with those of standard solutions of phenolphthalein and
R-nitrophenol.

6.

Freund's Adjuvant-Induced Rat Paw Edema
Polyarthritis was induced in rats by treatment with

complete Freund's adjuvant according to the method of
Pollock and Brown (1971).
Male rats were treated daily for 17 days with either
saline (ip), 75 mg/kg f40SA adjusted to pH 7.0 with NaOH
(ip), or 2 mg/kg triamcinolone (sc).

On the second treat-

ment day, 0.1 ml Freund's complete adjuvant, containing 10
mg heat-killed !i;icobacterium butyricum per milliliter of
15 % mannide monooleate in paraffin oil, was injected into
the sub-plantar tissue of the hind paw, using a 26 gauge
needle.

The paw volume was

determ~ned

immediately

plethysmographically and again on day 18, and edema formation calculated.
7.

Induction of Mouse Lun g Hemorrhage and Lung Hemoglobin

Determination
Lung hemorrhage was induced by sudden decompression, a
method developed by Majovski et al. (1944).
vacuum sink was evacuated to 40 mm Hg.

A 30 liter

Mice in a 1.5

liter test chamber at atmospheric pressure were subjected
to the lower pressure by the opening of a stopcock.

Within

20 seconds the pressure in t he two chambers equilibrated at
70 mm Hg.

The mice died within 60-90 seconds and were

removed from the chamber after two minutes.

The lungs were

18
rapidly excised, weighed, homogenized in 25 volumes of
cyanomethemoglobin reagent and centrifuged to sediment
tissue.

The supernatant was exami ned for hemoglobin con-

tent by determining absorbance at 540 nm.

The .re maining

homogenate was dried to constant weight at 85°c.
were reported as mg hemoglobin per mg dry lung.

Results
The re-

sultin g values were compared to thos e of control animals
maintained at atmospheric pressure.

Animals were admin-

istered (ip) saline, 300 mg/kg e40SA, 300 mg/kg phloroglucinol,
o r 100 mg/ kg

8.

pl~enylbut azone

1.5 hours prior to sacrifice.

In vivo Antagoni sm of Curare, Strychni ne, or Tetrodotoxin

in Mice

Lethal doses of curare, strychnine, or tetrodoto xin
were administered to mice to investigate antagonism to
t hes e agents.

The Eisenian extract at a dose of 300 mg/kg

or saline was administered intraperitoneally to mice 30
minutes prior to the administration (ip or sc) of either
curare (0.28-0.60 mg/kg) , strychnine (2.0 mg/kg), or
tetrodotoxin (12 µg/kg).

These doses are close to the

respective LD

1
s. The number of animals injected and
50
the number of survivo rs were recorded.

9,

Determinat ion of Acetylcholinesterase Activity
The activity of rat brain acetylcholinesterase was

estimated by the manometric method suggested by DuBois and
Mangun (1 947) employing the Warburg apparatus.
Male rats were administered (ip) either saline or 300
mg/kg ec40SA one hour prior to sacrifice for brain excision .

19.

Ten percent brain homogenates were prepared in calciumfree Ringer-bicarbonate buffer .

One-half milliliter of

homogenate and 2.2 ml buffer were transferred to the main
compartment of the Warburg flask.

In vitro experiments in-

clud ed the addition of ec40SA at a concentration of 5 mg/ml
to the main compartment.

The flasks were flushed for 5

minutes with 95:5 N2 :co 2 while they equilibrated to the
temperature of the water bath (38°c). The reaction was
initiated by tipping into the main compartment the contents
of the side-arm ·(0.3 ml of 0.1 M acetylcholine chloride).
After another 5 minute equilibration, the manometer readings of the amount of

co 2

produced by the enzymatic

hydrolysis of the acetylcholine were recorded at 5 minute
intervals for 30 minutes.

The

co 2

production was corrected

for both tissue and acetylcholine blanks and for thermobarometer changes.
10.

Cat Sciatic Nerve-Gastrocnemius Muscle Preparation
The in vivo cat sciatic nerve-gastrocnemius muscle

preparation was utilized to quant itate curare antagonism.
A 3.2 kg cat was anesthetized with 1.5 g/kg urethane
(ip).

The left jugular vein was cannulated and used for

infusion of drugs.

The right carotid artery was cannul ate d

and connected to a Statham blood pressure transducer which
was in turn wired to a Grass polygraph amplifier to monitor
blood pressure.
prevent clottin g .

Forty units/kg of heparin were infused to
An automatic respirator was connected

to a tracheal cannula.

The left gastrocnemius muscle was
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connected to a Grass force transducer which was in turn
wired to a Grass polygraph amplifier to record muscle
activity.

The left sciatic nerve received a 1.0 V

stimulus lasting 0.1 msec at a rate of 12/minute.

This

stimulus effected an initial contractile force of 980
dynes.

d-Tubocurarine chloride was infused until a 70 %

reduction in contractile force was obtained.

The follow-

ing drugs were infused, in order, over periods of 3, 6,
or 9 minutes respectively:

0.18 mg physostigmine, 30 mg

phloroglucinol, or 180 mg e40SA.

Additional curare was

infused between drugs as needed to reinstate the reference
curarization level.
11.

Determination of 0-Ethyl 0-(4-nitrophenyl) phenylphos-

phonothioate Detoxification.
The detoxification of 0-ethyl 0-(4-nitrophenyl)
phenylphosphonothioate (EPN) was estimated by measuring
the formation of the resultant £-nitrophenol according to
the method of Neal and DuBois (1965).
To an incubation mixture containing 1.3 µmoles NADP,

3.3 µmoles glucose-6-phosphate, 0.2 ml EPN-buffer and sufficient water to make a total volume of O. 8 ml was added
0.1 ml 20% rat liver homogenate in 1.15% KCl containing
O. 25 % nicotinamide.

'l'he EPN-buffer was prepared by dis-

solving 7.0 mg EPN in 1.0 ml 1:4 ethanol: propylene glycol
and adding 0.5 ml of this solution to 5.0 ml of 0.1 M
phosphate buffer, pH 7.8.
Incubation was carried out at 37°c for 60 min .

The
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reaction was terminated by adding 2.5 ml cold acetone to
the reaction flask.

The flask contents were transferred

to centrifuge tubes containing 0.2 ml glycine-NaOH buffer
(0.5 M, pH 9.5).

The tubes were centrifuged and the

absorbance of the supernatant was determined at 410 nm
versus a blank to which tissue had been added at the
termination of the incubation.

The amount of £-nitrophenol

formed was determined by comparison with the absorbance of
known quantities of the chemical.
12 .

Determination of L-Tryptophan Pyrrolase Activity
L-tryptophan pyrrolase activity of rat liver homoge-

nates was estimated through assay of the end product
kyn urenine, according to the method of Knox and Mehler
(1 95 0).
Incubations were carried out at 37°c for 60 minutes
in media con taining 7.5 mmo les L-tryptophan, 2.0 ml of
0.1 M phosph ate buffer, pH 7.0, and 0.8 ml 25% liver
homogenate in 0.15 M KCl in a total volume of 4.0 ml.
Por in vitro investigation, 1.94 mg of phloroglucinol or
f40SA was added.

To examine the in vivo effects of drugs

on the enzyme, animals were injected (ip) 1.5 hours prior
to sacrifice with saline, 300 mg/kg phloroglucinol, or
300 mg/kg e40SA; or with 35 mg/kg hydrocortisone four
hours prior to sacrifice for liver excision.
The reaction was terminated by the addition of 2.0
ml of 15% metaphosphoric acid.

The flask contents were

filtered and a 3.0 ml aliquot of the filtrate was
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neutralized with 1.0 ml of 1 N NaOH.

The absorbance was

then determined at 365 nm versus a blank to which the .
homogenate had been added after the metaphosphoric acid.
The amount of kynurenine formed was calculated from the
absorbance of solutions of kynurenine of known concentration.
13.

Determination of Estrogenic Activity
To determine estrogenic activity, immature female

rats were injected daily for three days with either
saline (ip), 308 . mg/kg f40SA (ip), or 25 µg/animal
estradiol-17-B(sc).

The estradiol was prepared by

diluting 1.0 ml of a 25 mg/100 ml 95% ethanol stock
solution wit h 4.0 ml saline .

On the fourth day, the

uterus was excised, weighed, and the uterine-to-body
weight ratio calculated.
D.

Statistical Methods
The 2-tailed Student's "t" test for independent means

was used to examine experimental means for statistical
significance.

The level of significance (P) was determined

by comparison of the computed"t" value with values from
standard tables.

All calculated "t" values were tested

at both the 0.05 and 0.01 probability levels for
rejection of the null hypothesis.
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IV

RESULTS

Inflammation
The extract was initially evaluated by means of the
albumin denaturation test , which is used to screen new
drugs for anti-inflammatory activity.
screening

proced~re

The results of this

are shown in Tables 1 and 2 .

Table 1

sho;;s that the heat denaturation of a 0 . 15% bovine serum
albumin solution was inhibited 96% by the addition of the
extract at a final concentration of 0.32 mg/ml, and that
there was a dose dependent relationship at lower concentrations.

'1.'able 2 shows th::tt the mo.del compound,

phloroglucinol, enhanced by at least 24% the denaturation
process.
Since the extract exhibited activity in the in vitro
anti-inflammatory test system, determination of its effect
in an intact animal model of inflammation would be valuable.
Table 3 summarizes the results of an anti-inflammatory
study employing as a model carrageenin-induced rat paw
edema.

The extract, administered at a dose of 75 mg/kg (ip)

one hour prior to carrageenin injection, inhibited edema
formation by 88%.

The administration of the potent anti-

inflammatory agent phenylbutazone (90 mg/kg) inhibited
edema production by 100% and also allowed for a partial
absorption of the injected carrageenin.

Administration of
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·Table 1.
c40SA
CONCENTRATION
mg/ml

Effect of C40SA on heat denaturation
of bovine serum albumin.

ABSO RBANCEa

r

CONTROL

o.o

.620

100

0.005

.550

89

0.01

.560

90

0.02

• 340

55

0.04

.345

56

0.08

.049

8

0.16

.036

6

0.32

.022

4

o.64

.090

15

aDeterrnined at 660 nm.

. 25 .

~able

2.

-PHLOROGLUCINOL
CONCENTRATION
mg/ml

Effect of phlordglucinol on heat
denaturation of bovine serum albumin.

ABSORBANCE a

% CONTROL

0.0

0.76

100

0.50

1.00

132

0.25

l. 00

132

0.125

1. 00

132

0. 062

1.00

132

0. 031

1.00

132

0.015

1.10

145

0.0075

0.95

125

0. 00 37

0.96

126

0.0018

0.94

124

0.0009

1.10

145

aDetermined at 660 nm.
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Table 3.

Effect of drugs on carrageenin-induced
rat paw edema.

· TREATMENTa
Saline

MEAN EDEMA

± SE 2

206

mm 3 (4)b

-% CONTROL
100

1363

±

cl40SA
( 75 mg/kg, ip)

163

±

69C

12

Phenylbutazone
(90 mg/kg, ip)

-100

±

71c

-7

738 ±

97d

54

Cortisone
(50 mg/kg, ip)

a

.
Drugs were administered 1 hour prior to carrageenin
injection.

bNumber of animals.
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the steroid cortisone (50 mg/kg ) inhibited edema formation
by

46%.

The effects of the above drugs were significant

at the P<.05 level.
Several experiments were undertaken to determine the
mechanism of action of the extract as an anti-inflammatory
agent in the carrageenin paw edema system.

The first of

these, a study of the effect of the extract on rat body
temperature, is summarized in Figure 1.

The extract, at

a dose of either 75 or 150 mg/kg, had a negligible effect
on body temperature over a period of four hours.
Since some compounds have been shown to possess antiinflammatory activity due to irritant properties, an expe riment was conducted to determine whether the extract
was an irritant by virtue of its acidity.

The carrageenin

paw edema model was again employed, and the extract, at a
dose of 100 mg/kg, was either buffered at or neutralized to
pH 7.4.

Table 4 shows the results of this study.

The

neutralized extract did not offer statistically significant
protection (76% of control) while the buffered material
inhibited edema formation by 42% (P .< .05).
Stabilization of the lysosomal membrane has also been
invoked as a me chanism of action of various anti-inflammatory
agents.

The degree of stabilization or labilization can be

inferred from the extent of release of the lysosomal marker
enzymes acid phosphatase and S-glucuronidase.

The extract

was so examined for it s effect on the lysosomal membrane.
The results of this study are shown in Tables 5 and 6.
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period of 4 hours. Each point r .e ~>resents
the mean temperature of.' 3 a.."1.imalo ~
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- Table 4.

Effect of neutralized or buffered ec40SA on
carrageenin-induced rat paw edema.

MEAN EDEMA ± SE, mm 3

TREATMENTa
Saline

1174

±

99

898

±

181

'

(6)b

% CONTROL

100

c

Neutralized
{100 mg/kg, ip)
Buffered d
( 100 mg/kg, ip)

678 ± 176e

aDrugs were administered 1 hour prior to carrageenin
injection.
bNurnber of animals.
cNeutralized to pH 7.4 with NaOH.
dBuffered at pH 7.4 with 0.2 M KH Po -Na HP0 4 .
2 4
2
ep < • 05

76

58
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The enzyme activities reported are corrected for direct drug
inhibition, if any.

Table 5 shows that acid phosphatase

activity is insensitive as an indicator of lysosomal membrane condition, since the powerful stabilizing agent
phenylbutazone inhibited enzyme release by only 7%.

How-

ever, phenylbutazone (0.309 mg/ml) and the extract at a
concentration of either 3.087 or 0.309 mg/ml offered significant (P < .01) inhibition of release of 8-glucuronidase
(30, 36, and 36 per cent of control respectively).
Phloroglucinol and 0.031 mg/ml f40SA were ineffective.
Table 6 shows that the extract retains its lysosomal
membrane stabilizing ability even when further chemically
purified.

The refined material offered statistically

si gnificant (P < .01) inhibition of release of
B-glucuronidase (43 % of con trol ).
The extract was further tested for anti-inflammatory
activity by means of the Freund 's adjuvant-induced rat paw
ede ma model of arthritis .
of this study.

Table 7 summarizes the results

The potent steroid triamcinolone inhibited

ede ma formation by 77% (P < .05), iri contrast to the extract, which provided negligible protection against this
type of inflammation.
Capillary fragility
The effect of the extract on capillary fragility as
determined by lung hemoglobin content following sudden
decompression was examined.
study.

Table 8 is a summary of this

None of the drugs tested, which included e40SA,
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Table 5.

Effect of drugs on lysosornal membrane stability
in vitro.

ENZYME ACTIVITYa ± SE (4)b (% CONTROL)
· DRUG

ACID PHOSPHATASEc

S-GLUCURONIDASEd

None

4·. 46 ± 0.16 (100)

o.66 ± 0.02 (100)

Phlorogl ud.nol
(0.309 mg/ml)

4.48 ± 0. 41 (100)

o.68 ± 0.02 (10 3)

Phenylbutazone
(0.309 mg/ml)

4.13 ± 0.08

(93)

0.20 ± 0.01

(30)f

(3.087 mg/ml)

3.66 ± 0.22

(82)e

0.24 ± 0.03

(36)f

f40SA
(0.309 mg/ml)

3.64 ± 0.16

( 82)e

0.24 ± 0.01

( 36) f

40SA
(0.031 mg/ml)

3.83 ± 0.22

( 86)

o.64 ± 0.02

(97)

f40SA

f

aE.xpressed as µmoles product/ml lysosomal fraction/20 min.
bNumber of animals .
cDetermined at 405 nm.
dDetermined at
540 nm.
ep <

• 05.

fp < . 01.

Table 6.

DRUG

Effect of f40SA and refined 40SA on lysosomal
membrane stability in vitro.

B-GLUCURONIDASE ACTIVITYa

±

SE (4)b (%CONTROL)

0.04 (100)

None

0.53

f40SA
(0.309 mg/ml)

0.20 ± 0.03

(38)c

Refined 40SA
(0.309 mg/ml)

0.23

(43)c

±

± 0.02

aExpressed as µmoles phenolphthalein/ ml lysosornal
fraction/ 20 min., determined at 540 nm.
bNumber of animals.
c p < .01.
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Table 7.

Antagonism of Freund's adjuvant-induced
rat paw edema

TREATMENT a
Saline
Triamcinolone
( 2 mg/kg , s c )
f40SAd
(75 mg/kg, ip)

MEAN EDEMA ± SE 2 mm 3 (6)b
3920

±

983

911

±

153c

%-

CONTROL
100

3079 ± 286

aDrugs were administered daily for 17 days; adjuvant
injected on second treatment day.
bNumber of animals.
Cp < • 05

dAdjusted to pH 1.0 with NaOH.
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79
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Table 8.

Effect of drugs on the mouse lung hemmorrhage
induced by sudden decompression.

TREATMENTa

'
b
MEAN mg HEMOGLOBIN /mg DRY LUNG ± SE(4)c
TABLE

CHAMBER

Saline

0.136 ± 0.005

0.154 ± 0.007

eliQSA
(300 mg/kg, ip)

0.145 ± 0.009

0.164 ± 0.006

Phloroglucinol
(300 mg/kg, ip)

0.129 ± 0.005

0.152 ± 0.008

Phenylbutazone
(100 mg/kg, ip)

0.165 ± 0.025

0.170 ± 0.006

8

Drugs were administered 1.5 hours prior to decompression.

bDeterminedat 540 nm.
cNumber of animals.
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phloroglucinol, and phenylbutazone, reduced capillary
fragility in this test system.
Curare, strychnine, and tetrodotoxin poisoning
The extract was tested for its ability to protect
against poisoning in mice induced by curare, strychnine,
or tetrodotoxin.

Table 9 shows that if both curare and

the extract were administered intraperitoneally, there
existed protection against curare lethality.

As shown in

Table 10, if the curare was administered subcutaneously
and the extract intraperitoneally, no protection was
exhibited by the extract.
Further experimentation was performed to investigate
the mechanism of action of the apparent curare antagonism
of the extract.

Table 11 shows that the material had a

negligible in vivo effect on rat brain cholinesterase
activity, in contrast to an in vitro inhibition of 53%
(P < .01).

The extract was also tested for its in vivo

effect on the curarized cat gastrocnemius muscle.

Jugular

infusion of 180 mg of e40SA over a period of nine minutes
exhibited no effect on the curarized muscle, in contrast
to the anticholinesterase agent physostigmine,

wh~ch

com-

pletely restored contractile force after infusion of 0.18
mg over a period of three minutes.
To determine whether the extract might protect against
poisoning due to other agents, its effects on strychnine
and tetrodotoxin lethality were examined.

In both cases,
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Table 9.

Protection against curare poisoning in
mice by e40SA.

CURARE DOSE
(mg/k.g, ip)

NUMBER OF SURVIVORS
SALINE

e40SA (300 mg/kg 2 iE)a

5/5b

5/5

0.37

3/5

5/5

o.45

2/5

4/5

0.52

1/5

5/5

0.60

0/5

5/5

0.

30

aAdministered 30 minutes prior to curare injection.
b

Number of survivors/number injected.
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Table 10.

CURARE DOSE
(mg/kg, sc)

Protection against curare poisoning in
mice by ec40SA.

NUMBER OF SURVIVORS
-SALINE
ec40SA (300 mg/kg, ip)a

0.28

lt/5b

5/5

0.36

3/5

lt/5

1~4

2/5

2/5

0.52

1/5

0/5

0.60

0/5

0/5

0.

aAdministered 30 minutes prior to curare injection.
bNumber of survivors/number injected.
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11.

Effect of ec40SA in vivo and in vitro on rat
brain cholinesterase activity-.-

TREATMENT

MEAN ENZYME ACTIVITYa ± SE (3)b

. % CONTROL

Saline

2.96 ± 0.20

100

ec40SA
(30 0 mg/kg,ip )c

3.17 ± 0.16

107

ec40SA
(5 mg/ml)

1.38 ± 0.16d

47

aExpressed as µmoles ACh/50 mg brain/10 min.
bNumber of animals.
cAdministered one hour prior to sacrifice.

39

the poison and the extract were administered by the intraperitoneal route.

Tables 12 and 13 show that the extract

does not protect against the lethality of either strychnine
or tetrodotoxin, respectively .
Liver microsomal enzymes
The possible effect of the extract on the activity of
the drug-metabolizing hepatic microsomal enzyme system was
determined by measuring the effect of the extract on the
metabolism of the pesticide EPN.
result s of the experiment.

Table 14 surrunarizes the

The classical inducing agent

phenobarbital significantly increased microsomal enzyme
activity by more than 4-fold (P < .01).

The extract was

ineffective in inducing this system after three days of
treatment or in inhibiting the activity when given 60
minutes before sacrificing the animals.
~tophan

pyrrolase

Table 15 summarizes the effects of various drugs on
rat liver tryptophan pyrrolase activity.

In vi VO

administration of hydrocortisone and f40SA resulted in
increased enzyme activity (322 % control, P < .01) and
inhibition (67% control, P < .01), respectively.

In vivo

administration of phloroglucinol had no effect on the
enzyme act1.vity, while the in vitro effect of phloroglucinol
was that of inhibition

(~8%

control, P < .01).

The

presence of the Eisenian extract resulted in an in vitro
inhibition of 82% (P < .01).
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Table 12.

Effect of ec40SA on strychnine poisoning in
mice.

STRYCHNINE ROUTE
(2 mg/kg)

NU MBER OF SURVIVORS
SALINE

ec40sA· (300 mg/kg, ip)a

ip

0/4b

0/4

SC

0/4

0/4

aAdministered 30 minutes prior to strychnine injection.
bNumber of survivors/number injected.
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Table 13.

Effect of f40SA on tetrodotoxin poisoning
in mice.

TREATMENTa

NUMBER OF SURVIVORS

Saline

l/4b

f40SA
(300 mg/kg, ip)

1/6

aAnimals were administered 12 µg/kg (ip) tetrodotoxin
30 min after protecting agent.
bHumber of survivors/number injected.
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Table 14.

Effect of drugs on EPNa detoxification.

TREATMENT

MEAN ENZYME ACTIVITYb

±

SE

. % CONTROL

Saline

1.8 ± 0.1 (6)c

100

Phenobarbital
(3 days, 50 mg/kg, ip)

7.8

0.5 (3)d

433

e40SA
(3 days, 300 mg/kg, ip)

1.4 ± 0.3 (3)

77

e40SA
( 1 hr. , 300 mg/kg, ip)

2.0 ± 0.1 (3)

111

±

aO-ethyl 0-4-nitrophenyl phenylphosphonothioate
v

bActivity expressed as µg PNP/50 mg liver/hr.
cNumber of animals.
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Table 15.

Effect of drugs in vivo and in vitro on rat
liver tryptophan{)yrrolase activity.

TREATMENT

MEAN ENZYME ACTIVITYa ± SE (4)b

% CONTROL

Saline c

20.6 ± 0.5

100

Hydrocortisoned
( 35 mg/kg, ip)

66.4 ± l.9e

322

Phloroglucinolc
( 300 mg/kg, ip)

19.8 ± 0.3

96

f40SA
(300 mg/kg, ip) c

13.7 ± 0.2e

67

Phloroglucinol
µg/ml)

9.9 ± 0. 3e

48

40SA
( 4 86 µg/ml

3.7

0.2e

18

(4 86
f

±

aExpressed as µmoles kynurenine/g liver/hr.
bNumber of animals.
cAdministered 1.5 hours prior to sacrifice.
dAdministered 4 hours prior to sacrifice.

1

Rat uterus
The extract was tested for possible estrogenic
activity by examining its ability to alter the uterine to
body weight ratio in immature female rats.
t he results of the study.

Table 16 shows

Estradiol-17-8 increased the

ratio more than 2-fold (P < .01), while the extract had
no effect on the ratio.

Table 16.

Effect of drugs on rat uterine weight.

TREATMENTa

Uterine Wt. x 103 ± S.E. (5)b
Body Wt .

% CONTROL

Saline (ip)

0.69 ± 0.06

100

Estradiol
(0 .5 µg/rat, sc)

1. 64 ±

ec40SA
(300 mg/kg, ip)

0.61 ± 0.04

o.o6c

aDrugs were administered daily for 3 days.

bNumber of animals .

238

88
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V

DISCUSSION

Inflammation
The extract was initially evaluated for pharmacolo gical
activity utilizin g the albumin heat denaturation screenin g
test for anti-inflammatory drugs .

A large number of anti-

:i.n.flammat ory drugs have been shown to inhibit the heat denaturation o f albumin solutions ( Grant

~al.,

1970).

Heat

denaturation is able to produce albumin a ggregates which
are i mmunolo gicall y distinct fr om the parent protein
( Maurer , 1959).
taneou sly

Such aggregates are known to occur spon-

( F oste r~

al., 1965); these spontaneous a ggre-

gates behave as anti gens in the etiology of at least one
i mmuno- inflammat ory disease, serum sickness nephritis
(Lirenman et al., 1967).
The extract inhibited albumin denaturation by 96 %, as
shown in Table 1, in contrast to the denaturation enhancement afforded by the model comp ound, phloroglucinol ( Table
2).

While the mechanism of such a stabilization is pres ently

unknown , it is possible that hydrogen bonding occurs between
the extract and the protein, thus increasing the stability
of the molecular structure.
The in vitro anti-inflammatory screen was followed by
in vivo anti-,inflammatory determinations utilizin g the
carrageenin-induced rat paw e dema model of inflammation,

which is least influenced by non-specific factors (Garattini
et al., 1965).

The mechanism by which carrageenin, a high

molecular weight polysaccharide, induces paw edema is as
controversial as the mechanisms of action of the agents which
inhibit this edema formation.

The following have been in-

voked as mediators of carrageenin-induced edema:

kinins and

5-hydroxytryptamine (5-HT) ( Crunkhorn and Meacock, 1971),
histamine (DiRos a et al., 1971), and activation of the complement system (DiRosa, 1972).

It is possible that the apparent

complement s ys tem activation reflects a mild antigen-antibody
response to carrageenin, since high molecular weight polysaccharides as well as proteins are capable of eliciting such
a response (Porter, 1967).

Thus, 5-HT and histamine release

may be secondary to comp lement activation.
Administration of the extract one hour prior to carrageenin injection inhibited the formation of edema by 88 %.
Accordingly, various experiments were undertaken to determine
the mechanism of action of this protection.

Since stimula-

tion of the adrenal cortex, either directly or indirectly
via the hypothalamus or pitui tary, can be related to antiinflammatory activity, the action of the extract was co mpared
with that of a large dose of cortisone (50 mg/kg, ip), which
inhibited ed ema production by 46 %.

Since cortisone afforded

only one-hal f th e inhibition offered by the extract, it is
unlikely that the extract could stimulate the production or
release of sufficient corticosteroid to reduce inflammation
by the extent exhibited.
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The thermogenic activity of new anti-inflammatory compounds must be determined since the peripheral vasodilation
which would accompany a rise in body temperature might
either promote edema, due to increased capillary permeability, or reduce edema, by more rapid removal of phlogistin.
The extract was tested for its effect on body temperature,
and it can be concluded from Figure 1 that the extract had
a negligible effect on body temperature over a period of
four hours.

Thus the anti-inflammatory activity of the

extract is not based on thermogenic effects.
Garattini et al., (1965) have shown that various compounds, when injected by the intraperitoneal route, can
inhibit edema formation in various models of inflammation
due to their properties as irritants.

A partial basis for

this phenomenon is decreased availability of circulating
fluid due to the draining of water into the peritoneal
cavity.

Accordingly, an experiment was undertaken to

determine if the extract was an irritant by virtue of its
acidity.

Employing the carrageenin model, extract was

tested which was maintained at pH 7.4 either by phosphate
buffering or sodium hydroxide neutralization.

The results

of the experiment are shown in Table 4, and it is evident
that although the anti-inflammatory potency of the extract
has been decreased by neutralization, the buffered material
retains statistically significant anti-inflammatory activity
which is one-h alf that of non-adjusted, acidic extract
solution.

Thu s the mechanism of action of the extract can

be partially, but not fully, explained on the basis of its
irritancy.
Labi lization of t he lysosomal membrane is known to
occur at site s of inj ury and has also been implicated as a
major factor in the development of inflammation, since
lysosomal enzymes possess the capacity to degrade co mpletely
the components of the connective tissue, such as collagen ,
protein-mucopolys accharide complexes, glycoprotein, and
elast in (Houck and Forscher, 1968; Ignarro, 1971).

Many

anti.-inflammatory agents have been shown to stabilize the
lysosomal membrane through their inhibition of the release
of the marker enzymes B-glucuronidase and acid phosphatase
from lysos omal preparations.
in this manner.

The extract was examined

It can be concluded from the data in Table 5

that the extract is as effective as phenylbutazone as a
lysosomal membrane stabilizing agent.
Since the crude extract might contain an impurity which
would account for the lysosomal membrane stabilization, a
refined sample of the extract was also tested for its ability
to inhibit the release of 8-glucuronidase from lysosomal
preparations.

The results, s11mmarized in Table 6, show that

the refined material is as effective as the crude in its
ability to stabilize the lysosomal membrane .
The extract was further tested for anti-inflammatory
activity by means of the adjuvant arthritis model, which
is a delayed hypersensitivity reaction.

Table 7 shows the

results of the study, and it can be concluded that the
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extract exerted no anti-inflammatory effect against this
type of inflammation .

The mechanism by which effective

agents, such as triamcinolone, combat this model of
arthritis is obscure, but may be in part due to lysosomal
stabilization (Pollock and Brown, 1971).
An hypothesis may be formulated to account for the contrasting effects of the extract on the two in vivo models
of inflammation.

11

Prima1•y" membrane stabilization ( stabili-

zation of membranes of whole cells, e.g., basophils,
platelets, or mas t cells) and "secondary" membrane stabilization {stabilization of the membranes of cell organelles,
e.g. lysosomes) apparently are involved in the etiology of
both carrageenin and Freund's edeffia.

The extract has been

shown to stabilize at least one type of membrane, that of
the lysosome.

However, Freund's edema may be more difficult

to suppress than carrageenin edema because of overwhelming
participation of the immunity mechanism in the case of the
former.
The extract, by virtue of its polysaccharide content,
might also act as a counter-irritant.
Capillary fragility
The extract was examined for its ability to decrease
capillary fragility.

It should be noted that the method of

Majovski (1944) was employed except in the comparison of
different treat men ts, for which a quantitative spectre. photometric assay for hemoglobin was used in place of the
arbitra ry qualitative assay originally described.
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The method employed is non-specific in that the underlying mechanism of a stabilizing agent cannot be di.fferentiated from the known possibilities, which include effects on
the 1) endothelial cell membrane, 2) endothelial cell junction, and 3) sources of possible chemical intermediates
(such as basophils, and platelets, and plasma kinins).
None of the drugs tested enhanced capillary stability
I

(Table 8) in cont rast to the effect of phloroglucinol reported by Okanishi and Shimaoka (1952).

Close examination

of the results shows that the method is not sufficiently
sensitive to quantitate the possible stabilizing effects of
drugs, inasmuch as the chamber control animals exhibited
only a 13% increase in lung hemoglobin compared to the nonchamber animals.

This increase is not statis tically

significant.
Curare, strychnine , and tetrodotoxin poisoning
The extract was tested for its effecti veness as an
antagonist against curare, strychnine, and tet rodotoxin,
because of the report of Mogey and Young (1949) that
phloroglucinol acted as a mild curare ant agon ist in vitro.
These three agents act on the nervous sys te m dissimilarly:
1) curare, the classical neuromuscular bl ccker, competitively
blocks postjunctional acetylcholine recep or sites, 2)
strychnine, a CNS stimulant, acts by

bloc ~i ng

post-synaptic

inhibition, and 3) tetrodotoxin selective ly blocks axonal
conduction.
Since the extract was ineffective in pre venting curare
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poisoning when administered via a different route than that
of the curare, in contrast to the protection exhibited when
the routes of administration were identical (Tables 9-10),
a true pharmacological antagonism would seem an unlikely
mechanism of action of the extract.

This was supported by

demonstrating that 1) the extract was an ineffective in
vivo cholinesterase inhibitor (Table 11) and 2) the extract
exerted no antagonism to the action of curare on the in
vivo cat gastrocnemius muscle-sciatic nerve preparation.
An alternative mechanism of action might be based on
the occurrence of a chemical interaction of the negatively
charged extract molecule with the positively charged
quaternary nitrogen of the curare molecule.

Further ex-

perimentation in this context failed to support such a
mechanism:

while no protection was offered against the

lethality of strychnine, which contains an uncharged
tertiary nitrogen (Table 12), neither was there protection
a gai nst poisoning by tetrodotoxin which contains a
positively charged guanidinium group (Table 13).

An

untested hypothesis for the curare protection might be an
inhibition of absorption of the curare from the peritoneal
cavity.
Liver mi cro somal enzymes
In order to more fully characterize the action of a
new drug, its interaction with other drug s must be
examined.

One potential site of drug interaction is the

liver microsomal electron transport system, an enzyme
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system which is responsible for the biotransformation of a
wide variety of drugs and other chemical agents.

Most

important relative to drug interactions are the stimulation
(induction) and inhibition of the system.
The extract was tested for possible microsomal induction
or inhibition (Table 14) by measuring the effect on the
metabolism of the insectide EPN.

The extract was observed

to have no effect on microsomal enzymes after administration
daily for three days or one hour following a single dose.
Tryptophan

P.l.~.;olase

Tryptophan pyrrolase, located in the soluble fraction
of the liver cell, catalyzes the cleavage of the indole ring
from the nutritionally essential amino acid tryptophan.

The

resultant product, formyl kynurenine, is readily hydrolyzed
to kynurenine.

Tryptophan pyrrolase is important not only

for tryptophan degradation but also for the conversion of
tryptophan to niacin.

The enzyme is inducible; known induc-

ing agents include adrenal corticosteroids and tryptophan
itself.
Investigation of the effect of the extract on the
activity of tryptophan pyrrolase would provide a more complete characterization of the effects of the extract on
liver metabolism, in conjunction with the effects exerted on
the microsomal enzyme syste m, especially since Frieden et al.
(1961) reported that phloroglucinol inhibited tryptophan
pyrrolase in vitro.

Such an investigation wa s carried out

and the results, shown in Table 15, indicate that the

extract, both in vivo and in vitro, caused enzyme inhibition.
Such inhibition could result in nicotinic acid deficiency or
i.n increased synthesis of serotonin, which might result in
stimulation of cerebral activity.
Rat uterus
A variety of naturally occurring phenolic materials
have been shown to exhibit estrogenic activity (Biggers and
Curnow, 1954); the widespread metabolic consequences of
such activity se emed sufficient justification for determining

~1e ther

the extract acted in a similar manner.

The uterus, target organ for estrogen, is most frequently
employed to bioassay for estrogenic activity .

The response

of this organ to estrogenic stimulation is biphasic in
nature:

initially, hyperemia and imbibition of water occur,

followed later by hypertrophy and hyperplasia; thus an
increase in the uterine to body weight ratio can be demonstrated.
The ext ract was found to cause neither estrogenic
stimulation nor retrogression of this organ (Table 16).
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VI

1.

SUMMARY AND CONCLUSIONS

An eitract from Eisenia bicyclis containing principally
a polyphenolic polymer inhibited the heat denaturation
of a 0.15% bovine serum albumin by 96% when added to
the i n cubation medium at a concentration of 0.32 mg/ml.
This was suggestive of possible anti-inflammatory
activity.

2.

As determined by paw volume changes , administration of
the extract at a dose of 75 mg/kg one hour prior to
carrageenin injection inhibited edema production by 88%.

3.

The ability of the extract to suppress carrageenin
edema was apparently not due to pituitary-adrenal
stimulation, since a large dose of cortisone (50 mg/kg)
provided only one-half the protection afforded by the
extract.

Nor was the anti-inflammatory effect due to

changes in body temperature, which remained unchanged
over a period of four hours after administration of a
dose of either 75 or 150 mg/kg.

4.

The anti-inflammatory effect of the extract was parti ally
due to its irritant properties, since buffering a dose
of 100 mg/kg provided only one-half the protection
afforded by a non-buffered dose.

The extract may also

act against inflammation by stabilizing the lysosomal
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membrane, since in vitro 309

~g

of the extract per

milliliter of incubation medium inhibited by 64% the
release of the marker enzyme e-glucuronidase from rat
liver lysosomes .

5.

The extract administered at a dose of 75 mg/kg daily
for 17 days offered no protection against rat paw
edema induced by Freund's complete adjuvant .

6.

No decrease in capillary fragility of the mouse lung,
as determined by hemoglobin content following sudden
decomp ressi on, was observed 1.5 hours after pretreatment with the extract at a dose of 300 mg/kg ..

7.

The material administered to mice at a dose of 300 mg/kg
30 minutes prior to administration of lethal doses of
curare exhibited protection against curare poisoning
only if the routes of administration were identical.

8.

The mechanism of action of the apparent curare antagonism of the extract appeared to be chemical rather than
pharmacological, since the material had no effect on
either the curarized cat gastrocnemius muscle in vivo
or the activity of rat brain cholinesterase in vivo.
An exact chemical mechanism cannot be formulated because the material was ineffective in preventing
poisoning by either another positively charged toxin,
tetrodoto xin, or an uncharged poison, strychnine.

9.

The extract was observed to have no effect on liver
microsomal enzyme activity after

administr~tion

of 300

mg/kg daily for three days or one hour following a
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single dose of 300 mg/kg.
10.

The administration of the extract at a dose of 300
mg/kg 1.5 hours prior to sacrifice resulted in 33%

inhibition of the activity of tryptophan pyrrolase.
The presence of the extract at a concentration of

486 µg/ml resulted in an in vitro inhibition of 82%.
11.

The extract, administered at a dose of 300 mg/kg
daily for three days, did not alter the uterine to

body weight ratio in immature female rats.
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